184 related articles for article (PubMed ID: 33324218)
21. Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21.
Kumarswamy R; Volkmann I; Jazbutyte V; Dangwal S; Park DH; Thum T
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):361-9. PubMed ID: 22095988
[TBL] [Abstract][Full Text] [Related]
22. The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells.
Wang J; He W; Xu X; Guo L; Zhang Y; Han S; Shen D
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607031
[TBL] [Abstract][Full Text] [Related]
23. Linagliptin but not Sitagliptin inhibited transforming growth factor-β2-induced endothelial DPP-4 activity and the endothelial-mesenchymal transition.
Shi S; Kanasaki K; Koya D
Biochem Biophys Res Commun; 2016 Feb; 471(1):184-90. PubMed ID: 26826382
[TBL] [Abstract][Full Text] [Related]
24. microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney.
Srivastava SP; Hedayat AF; Kanasaki K; Goodwin JE
Front Pharmacol; 2019; 10():904. PubMed ID: 31474862
[TBL] [Abstract][Full Text] [Related]
25. H19/TET1 axis promotes TGF-β signaling linked to endothelial-to-mesenchymal transition.
Cao T; Jiang Y; Li D; Sun X; Zhang Y; Qin L; Tellides G; Taylor HS; Huang Y
FASEB J; 2020 Jun; 34(6):8625-8640. PubMed ID: 32374060
[TBL] [Abstract][Full Text] [Related]
26. MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart.
Liang C; Gao L; Liu Y; Liu Y; Yao R; Li Y; Xiao L; Wu L; Du B; Huang Z; Zhang Y
Life Sci; 2019 May; 224():12-22. PubMed ID: 30872181
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-142-3p inhibits high-glucose-induced endothelial-to-mesenchymal transition through targeting TGF-β1/Smad pathway in primary human aortic endothelial cells.
Zhu GH; Li R; Zeng Y; Zhou T; Xiong F; Zhu M
Int J Clin Exp Pathol; 2018; 11(3):1208-1217. PubMed ID: 31938215
[TBL] [Abstract][Full Text] [Related]
28. Ghrelin protects against obesity-induced myocardial injury by regulating the lncRNA H19/miR-29a/IGF-1 signalling axis.
Liu Y; Xu XY; Shen Y; Ye CF; Hu N; Yao Q; Lv XZ; Long SL; Ren C; Lang YY; Liu YL
Exp Mol Pathol; 2020 Jun; 114():104405. PubMed ID: 32084395
[TBL] [Abstract][Full Text] [Related]
29. Long Noncoding RNA H19 Promotes Osteoblast Differentiation Via TGF-β1/Smad3/HDAC Signaling Pathway by Deriving miR-675.
Huang Y; Zheng Y; Jia L; Li W
Stem Cells; 2015 Dec; 33(12):3481-92. PubMed ID: 26417995
[TBL] [Abstract][Full Text] [Related]
30. Melatonin Alleviates Hyperglycemia-Induced Cardiomyocyte Apoptosis via Regulation of Long Non-Coding RNA H19/miR-29c/MAPK Axis in Diabetic Cardiomyopathy.
Tang H; Zhong H; Liu W; Wang Y; Wang Y; Wang L; Tang S; Zhu H
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890121
[TBL] [Abstract][Full Text] [Related]
31. FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway.
Li J; Shi S; Srivastava SP; Kitada M; Nagai T; Nitta K; Kohno M; Kanasaki K; Koya D
Cell Death Dis; 2017 Aug; 8(8):e2965. PubMed ID: 28771231
[TBL] [Abstract][Full Text] [Related]
32. LncRNA H19/microRNA-675/PPARα axis regulates liver cell injury and energy metabolism remodelling induced by hepatitis B X protein via Akt/mTOR signalling.
Liu Y; Xu L; Lu B; Zhao M; Li L; Sun W; Qiu Z; Zhang B
Mol Immunol; 2019 Dec; 116():18-28. PubMed ID: 31574452
[TBL] [Abstract][Full Text] [Related]
33. LncRNA H19 secreted by umbilical cord blood mesenchymal stem cells through microRNA-29a-3p/FOS axis for central sensitization of pain in advanced osteoarthritis.
Yang Q; Yao Y; Zhao D; Zou H; Lai C; Xiang G; Wang G; Luo L; Shi Y; Li Y; Yang M; Huang X
Am J Transl Res; 2021; 13(3):1245-1256. PubMed ID: 33841653
[TBL] [Abstract][Full Text] [Related]
34. miR-222 inhibits cardiac fibrosis in diabetic mice heart via regulating Wnt/β-catenin-mediated endothelium to mesenchymal transition.
Wang Z; Wang Z; Gao L; Xiao L; Yao R; Du B; Li Y; Wu L; Liang C; Huang Z; Li P; Zhang Y
J Cell Physiol; 2020 Mar; 235(3):2149-2160. PubMed ID: 31389030
[TBL] [Abstract][Full Text] [Related]
35. Long Noncoding RNA H19 Acts as a Competing Endogenous RNA to Mediate CTGF Expression by Sponging miR-455 in Cardiac Fibrosis.
Huang ZW; Tian LH; Yang B; Guo RM
DNA Cell Biol; 2017 Sep; 36(9):759-766. PubMed ID: 28753062
[TBL] [Abstract][Full Text] [Related]
36. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
37.
Wang B; Yao K; Wise AF; Lau R; Shen HH; Tesch GH; Ricardo SD
Clin Sci (Lond); 2017 Mar; 131(5):411-423. PubMed ID: 28053239
[TBL] [Abstract][Full Text] [Related]
38. Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis.
Srivastava SP; Shi S; Kanasaki M; Nagai T; Kitada M; He J; Nakamura Y; Ishigaki Y; Kanasaki K; Koya D
Sci Rep; 2016 Jul; 6():29884. PubMed ID: 27425816
[TBL] [Abstract][Full Text] [Related]
39. Effect of lncRNA-MIAT on kidney injury in sepsis rats via regulating miR-29a expression.
Zhang Y; Zhang YY; Xia F; Yang AX; Qian JX; Zhao H; Tao WY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10942-10949. PubMed ID: 31858562
[TBL] [Abstract][Full Text] [Related]
40. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
